Thopaz+ Digital Chest Drainage System

With Thopaz+, Medela sets a new standard in chest drainage in terms of mobility, objective digital data and ease of use, Thopaz+, features the latest digital technology allowing healthcare professionals to make accurate decisions based on precise data and monitoring.

Improving outcomes and streamlining care - clinically proven

Currently about 85% of all thoracic chest drainage is managed by traditional systems using external support like wall suction on immobilised patients. This method allows for a subjective assessment of parenchymal leakage only and places the burden of monitoring duties on the medical staff.

The use of modern chest drainage systems from Medela, has been clinically proven to provide cost reductions by streamlining surgical care and post-procedural monitoring of patient status.

In close collaboration with medical experts and based on clinical research, Medela continues to set standards in modern chest drainage therapy.

10 years of Digital Chest Drainage Research and Innovation

From Heber-principle to digital systems, thoracic surgery has significantly changed and improved over the course of time – so has chest drainage. Ten years ago, chest drainage therapy as we knew it was completely overhauled with the introduction of digital drainage systems.

Based on science and innovative research, Medela has continuously proven to be the technology leader in this area. In 2007, Thopaz was introduced as the first truly portable digital drainage system. In 2014, Thopaz+ was launched, the first digital drainage monitoring system with electronic measurement of air-leak and drainage volume.

Vast amounts of clinical and global experience show how 10 years of digital drainage have significantly impacted the medical field:

  • 2018: NICE (an executive non-departmental public body of the Department of Health in the UK) recommends Thopaz+ for managing chest drains (1). "At a national level, adopting Thopaz+ is expected to save around £8.5 million per year in England."
  • 2018: New AWMF S3-Leitlinie (Association of the Scientific Medical Societies in Germany S3 Guideline) (2) recommends digital drainage for primary/secondary PNX.
  • 2016: 1,000,000 patients treated with Thopaz or Thopaz+.
  • 2015: Clinical data of 120 cardiac patients showed more efficient fluid collection due to continuous suction (3).
  • 2014: CADTH appraisal for compact digital chest drainage systems (4).
  • 2014: Data of international multicenter study shows significant reduction of chest tube duration and LOS (5).
  • 2011: Thopaz wins a UK Patient Safety Award (6).
  • 2011: Publication of "Consensus definitions ESTS, AATS and STS to promote an evidence-based approach to management of the pleural space"(7).
  • 2010: Cardiac Unit of University Hospital Jena/ Germany starts using Thopaz.
  • 2008: Robert J. Cerfolio, thoracic surgeon and thought leader acknowledges the benefits of Thopaz after Pulmonary Resection (8).
  • 2007: First patient on Thopaz.

[1] NICE Guidance MTG37:

[2] AWMF S3-Leilinie: Diagnostik und Therapie von. Spontanpneumothorax und postinterventionellem Pneumothorax

[3] Barozzi, L. et al., 2015: Do we still need wall suction for chest drainage? J Cardiovascular Surgery.2015;56(Supp.1)102.

[4] Rapid Response Report: Compact Digital Thoracic Drain Systems for the Management of Thoracic Surgical Patients: A Review of the Clinical Effectiveness, Safety, and Cost-Effectiveness .

[5]Pompili, C. et al., 2014: Multicenter International Randomized Comparison of Objective and Subjective Outcomes Between Electronic and Traditional Chest Drainage Systems. Ann Thorac Surg. 98: 490–497.

[6] Read

[7] Brunelli, A. et al., 2011: Consensus definitions to promote an evidence-based approach to management of  the pleural space. A collaborative proposal by ESTS, AATS, STS, and GTSC.  Eur J Cardiothorac Surg.: 40(2):291-7.

[8] Cerfolio, Robert J. et al., The Benefits of Continuous and Digital Air Leak Assessment After Elective Pulmonary Resection: A Prospective Study.The Annals of Thoracic Surgery , Volume 86 , Issue 2 , 396 - 401.


Benefits of Thopaz+

The digital technology used in Thopaz+ allows medical staff to monitor patients and record key therapeutic indicators such as air leak, fluid drainage and intrapleural pressure. Real-time recording of objective data allows the medical team to streamline care delivery and improve patient outcomes.

  • Electronically measure and record all key parameters used in chest drainage management
  • Select optimal level of patient chest pressure
  • Ease of use streamlines surgical care for doctors and provide convenience for nurses and hospital staff
  • Improves patient satisfaction and comfort by providing full mobility with quiet pump operation
  • Reduces patient length of stay in hospital and helps to control costs

Early decision making using objective real-time data.

Greater convenience for doctors and nursing staff alike due to regulated pressure and early warning of potential backflow.

Compact, hygienic and easy-to-clean system offering intuitive operation and handling.

Lightweight design and rechargeable batteries enhance patient satisfaction allowing full mobility.

Medela offers a complete range of disposables and accessories for Thopaz+

Related videos
Related videos

Thopaz+ product video

The Royal Alexandra Hospital Foundation on Thopaz+
See how the Royal Alexandra Hospital Foundation (Canada) values the advantages of Thopaz+

More information
More information

Supporting surgery with medical technology

Read more

Patient care

Read more

Multicenter international Randomized Comparison of Objective and Subjective Outcomes Between Electronic and Traditional Chest Drainage Systems; Pompili C., Detterbeck F., Papagiannopolous K., Sihoe A., Vachlas K., Maxfield M., Lim H., Brunelli A.; The Annals of Thoracic Surgery; accepted for publication 2014.

Impact of the learning curve in the use of a novel electronic chest drainage system after pulmonary lobectomy: a case-matched analysis on the duration of chest tube usage. Pompili C., Brunelli A., Salati M., Refai M., Sabbatini A., Interact Cardiovasc Thorac Surg. 2011 Nov. ; 13(5) : 490-3.